Search

Nicole Erin Kinsey White

Examiner (ID: 18489, Phone: (571)272-9943 , Office: P/1648 )

Most Active Art Unit
1648
Art Unit(s)
1671, 1672, 1648
Total Applications
1130
Issued Applications
560
Pending Applications
136
Abandoned Applications
472

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5687721 [patent_doc_number] => 20060286036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Methods and compositions for inhibiting HIV infection' [patent_app_type] => utility [patent_app_number] => 11/408551 [patent_app_country] => US [patent_app_date] => 2006-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11962 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286036.pdf [firstpage_image] =>[orig_patent_app_number] => 11408551 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/408551
Methods and compositions for inhibiting HIV infection Apr 20, 2006 Issued
Array ( [id] => 5732309 [patent_doc_number] => 20060257426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Nanoemulsion vaccines' [patent_app_type] => utility [patent_app_number] => 11/403316 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 74382 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257426.pdf [firstpage_image] =>[orig_patent_app_number] => 11403316 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/403316
Nanoemulsion vaccines Apr 12, 2006 Abandoned
Array ( [id] => 5922512 [patent_doc_number] => 20060240516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Interacting polypeptide comprising a heptapeptide pattern and a cell penetration domain' [patent_app_type] => utility [patent_app_number] => 11/396196 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18815 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240516.pdf [firstpage_image] =>[orig_patent_app_number] => 11396196 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/396196
Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain Mar 29, 2006 Issued
Array ( [id] => 5514285 [patent_doc_number] => 20090214591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Immunogens for Vaccines Against Antigenically Variable Pathogens and Diseases' [patent_app_type] => utility [patent_app_number] => 11/908942 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11178 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214591.pdf [firstpage_image] =>[orig_patent_app_number] => 11908942 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908942
Immunogens for Vaccines Against Antigenically Variable Pathogens and Diseases Mar 16, 2006 Abandoned
Array ( [id] => 13335 [patent_doc_number] => 07807437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Variants of hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/375580 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18018 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807437.pdf [firstpage_image] =>[orig_patent_app_number] => 11375580 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/375580
Variants of hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof Mar 14, 2006 Issued
Array ( [id] => 5888964 [patent_doc_number] => 20060275897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'HIV vaccines based on Env of multiple clades of HIV' [patent_app_type] => utility [patent_app_number] => 11/376484 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 110 [patent_figures_cnt] => 110 [patent_no_of_words] => 37733 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275897.pdf [firstpage_image] =>[orig_patent_app_number] => 11376484 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/376484
HIV vaccines based on Env of multiple clades of HIV Mar 14, 2006 Abandoned
Array ( [id] => 196442 [patent_doc_number] => 07638319 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Method for determining co-receptor selectivity of Human Immunodeficiency Virus-1' [patent_app_type] => utility [patent_app_number] => 11/369010 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 9322 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638319.pdf [firstpage_image] =>[orig_patent_app_number] => 11369010 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/369010
Method for determining co-receptor selectivity of Human Immunodeficiency Virus-1 Mar 6, 2006 Issued
Array ( [id] => 6252195 [patent_doc_number] => 20100028383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Chemically defined stabiliser' [patent_app_type] => utility [patent_app_number] => 11/908028 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10212 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028383.pdf [firstpage_image] =>[orig_patent_app_number] => 11908028 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908028
Chemically defined vaccine stabiliser Mar 6, 2006 Issued
Array ( [id] => 4820175 [patent_doc_number] => 20080226548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Methods of Applying Ionization Radiation for Therapy of Hiv Infection' [patent_app_type] => utility [patent_app_number] => 11/885769 [patent_app_country] => US [patent_app_date] => 2006-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11045 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226548.pdf [firstpage_image] =>[orig_patent_app_number] => 11885769 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/885769
Methods of Applying Ionization Radiation for Therapy of Hiv Infection Mar 5, 2006 Abandoned
Array ( [id] => 5785382 [patent_doc_number] => 20060205040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Compositions for use in identification of adventitious viruses' [patent_app_type] => utility [patent_app_number] => 11/368233 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 28763 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205040.pdf [firstpage_image] =>[orig_patent_app_number] => 11368233 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/368233
Compositions for use in identification of adventitious viruses Mar 2, 2006 Abandoned
Array ( [id] => 5514286 [patent_doc_number] => 20090214592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Adjuvant composition comprising aluminium phosphate and 3D-MPL' [patent_app_type] => utility [patent_app_number] => 11/884610 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7473 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214592.pdf [firstpage_image] =>[orig_patent_app_number] => 11884610 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/884610
Adjuvant composition comprising aluminium phosphate and 3D-MPL Feb 15, 2006 Abandoned
Array ( [id] => 6126480 [patent_doc_number] => 20110086338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'Bacteriophage/Quantum-Dot (Phage-QD) Nanocomplex to Detect Biological Targets in Clinical and Environmental Isolates' [patent_app_type] => utility [patent_app_number] => 11/884604 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14610 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086338.pdf [firstpage_image] =>[orig_patent_app_number] => 11884604 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/884604
Bacteriophage/Quantum-Dot (Phage-QD) Nanocomplex to Detect Biological Targets in Clinical and Environmental Isolates Feb 15, 2006 Abandoned
Array ( [id] => 270203 [patent_doc_number] => 07563437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Methods and compositions for impairing multiplication of HIV-1' [patent_app_type] => utility [patent_app_number] => 11/353293 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 11737 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563437.pdf [firstpage_image] =>[orig_patent_app_number] => 11353293 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/353293
Methods and compositions for impairing multiplication of HIV-1 Feb 12, 2006 Issued
Array ( [id] => 4839819 [patent_doc_number] => 20080280305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Assays for Detecting Hiv-1 Tat Protein in Hiv-1 Infection' [patent_app_type] => utility [patent_app_number] => 11/795671 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4308 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280305.pdf [firstpage_image] =>[orig_patent_app_number] => 11795671 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/795671
Assays for Detecting Hiv-1 Tat Protein in Hiv-1 Infection Feb 12, 2006 Abandoned
Array ( [id] => 393785 [patent_doc_number] => 07297477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-20 [patent_title] => 'Methods and compositions for detecting viral nucleic acid in a cell' [patent_app_type] => utility [patent_app_number] => 11/353719 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 7424 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/297/07297477.pdf [firstpage_image] =>[orig_patent_app_number] => 11353719 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/353719
Methods and compositions for detecting viral nucleic acid in a cell Feb 12, 2006 Issued
Array ( [id] => 5154297 [patent_doc_number] => 20070037180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Site-specific immunization in order to establish antibodies with specificity for the E7 oncoprotein of high-risk HPV\'s' [patent_app_type] => utility [patent_app_number] => 11/350453 [patent_app_country] => US [patent_app_date] => 2006-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3184 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037180.pdf [firstpage_image] =>[orig_patent_app_number] => 11350453 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/350453
Site-specific immunization in order to establish antibodies with specificity for the E7 oncoprotein of high-risk HPV's Feb 8, 2006 Abandoned
Array ( [id] => 6479442 [patent_doc_number] => 20100041732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'METHODS FOR IDENTIFYING COMPOUNDS THAT INHIBIT HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 11/815311 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8480 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041732.pdf [firstpage_image] =>[orig_patent_app_number] => 11815311 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/815311
METHODS FOR IDENTIFYING COMPOUNDS THAT INHIBIT HIV INFECTION Feb 5, 2006 Abandoned
Array ( [id] => 4475808 [patent_doc_number] => 07906122 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination' [patent_app_type] => utility [patent_app_number] => 11/345624 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 15884 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906122.pdf [firstpage_image] =>[orig_patent_app_number] => 11345624 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/345624
Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination Feb 1, 2006 Issued
Array ( [id] => 5912927 [patent_doc_number] => 20060127989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Antigenic fragment of human T-lymphotropic virus' [patent_app_type] => utility [patent_app_number] => 11/345110 [patent_app_country] => US [patent_app_date] => 2006-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4368 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127989.pdf [firstpage_image] =>[orig_patent_app_number] => 11345110 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/345110
Antigenic fragment of human T-lymphotropic virus Jan 30, 2006 Abandoned
Array ( [id] => 5558735 [patent_doc_number] => 20090270312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'HIV-I GP41 FUSION PEPTIDES FOR IMMUNOMODULALTION' [patent_app_type] => utility [patent_app_number] => 11/722064 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14749 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270312.pdf [firstpage_image] =>[orig_patent_app_number] => 11722064 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/722064
HIV-I GP41 FUSION PEPTIDES FOR IMMUNOMODULALTION Jan 23, 2006 Abandoned
Menu